[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$vani
$vani sees a surge in social media engagement, with mentions up significantly. However, concerns about side effects and costs create a mixed outlook for the drug.
About $vani
Analysis of social media data and insights on the pharmaceutical industry, specifically focusing on the drug $vani.
Insights #
- $vani mentions is at XXX which is XXX% higher than it's daily average.
- $vani sentiment is up XXXXX% from the previous week.
- $vani mentions is up XXX% from the previous month.
- $vani Mentions hit a high of XXX for the day
- $vani Mentions hit an all time of XXX for the day
Engagements: XXXXX #
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXX +274%
1-Year High: XXXXXX on 2025-07-17
1-Year Low: X on 2025-04-27
| Social Network | X |
|---|---|
| Engagements | XXXXX |
Mentions: XXX #
Mentions 24-Hour Chart Data
Current Value: XXX
Daily Average: XX
1 Week: XXX +32%
1 Month: XXXXX +224%
1-Year High: XXX on 2025-07-23
1-Year Low: X on 2025-04-27
| Social Network | X |
|---|---|
| Mentions | XXX |
Creators: XX #
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning $vani in the last XX hours which is up XXXX% from XX in the previous XX hours
Daily Average: XX
1 Week: XX -XX%
1 Month: XXX +159%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-04-27
The most influential creators that mention $vani in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @AponiaAnalytics | X | XXXXX | XX | XXXXX |
Sentiment: XX% #
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +42%
1 Month: XX% -XX%
1-Year High: XXX% on 2025-06-11
1-Year Low: XX% on 2025-06-24
Most Supportive Themes
- Cardiometabolic Benefits: (30%) Positive outcomes associated with GLP-1 receptor agonist therapy, including improved cardiometabolic outcomes, weight loss, and reduced risk of heart disease.
- Hormonal and Sleep Benefits: (15%) The potential of GLP-1 drugs to boost testosterone levels in men and improve sleep quality, leading to better weight loss results.
- Market Expansion: (10%) The expansion of Hims & Hers into Canada and the availability of Wegovy in Singapore, indicating market growth and accessibility.
- New Research and Developments: (5%) The emergence of new research and developments in GLP-1 therapies, including oral medications and gene editing approaches.
Most Critical Themes
- GLP-1 Drug Risks: (23%) Concerns about risks and side effects of GLP-1 drugs, including potential for optic nerve damage, gastroesophageal reflux disease, and mental health issues.
- Cost and Economic Concerns: (10%) Criticism of the high cost and economic inefficiency of GLP-1 drugs, particularly in the context of Medicare coverage.
- Unsupervised Use and Misleading Practices: (5%) Warnings against unsupervised use of weight-loss drugs and the potential for misleading advertising and pricing practices.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXXXX | XX% | XXX | X% |
| Total | XXXXX | XX% | XXXXX | XX% | XXX | X% |
Top assets mentioned In the posts about $vani in the last XX hours
Hims & Hers Health, Inc. (HIMS) Biogen Inc (BIIB) Self Crypto (SELF) GSK plc (GSK) DTE Energy Co (DTE) Teleflex, Inc. (TFX) Bytom (BTM) Lucid Group Inc (LCID) Veritaseum (VERI) Synthetify (SNY)
Top topics mentioned In the posts about $vani in the last XX hours
manat, sny, $hims, hims, $zldpf, $biib, qqq, meta, nke, dks, spy, mstr, nvda, lyft, adil, spx, riot, gibraltar pound, $rhhby, cuh, $wwb, corz, $tast, $sidu, nio, avgo, investment, stocks, coins storage, $self, acquisition, $gsk, pal, $airtp, $dte, shel, $tfx, $cste, $btm, $stem, $lcid, $vvpr, $veri, $prts, $add, $mtrx, $amlx, $crgx, owen, nmr, aur, wec, $cars, fwrd, $bdl, ip, oxsq, rl, $mysz, $aciu, amgn, ixhl, $vrax, patience, $ixhl, gem, axiom, 5aedd47nt2gjujoyctd2towobf3mp3urbslox4pzpump, elon musk, titan, $bpypp, $gryp, $tnk, $crgo, $doyu, china, $entx, $nrxp, $glto, $prok, $sny, sis, $cuh, bti, bnt, $uuuu, dfdv, payx, gib, $ecdaw, $bzfd
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"🦉 In T2DM patients exenatide reversed amygdala overactivation caused by dapagliflozin. Indicates direct CNS interaction. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"
@AponiaAnalytics on X 2025-07-27 17:25:15 UTC 5024 followers, XXX engagements
"🦉 Liraglutide increased intrinsic connectivity in the DMN of AD-risk individuals. Suggests central neural activity beyond glycemic effect. #GLP1 #Alzheimers $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"
@AponiaAnalytics on X 2025-07-27 17:24:59 UTC 5024 followers, XXX engagements
"🦉 GLP-1 receptor antagonist exendin-(939) reduced brain uptake of labeled GLP-1 and exendin-4 by 50%. Confirms receptor-mediated BBB transport. #GLP1 #dementia $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"
@AponiaAnalytics on X 2025-07-27 17:23:38 UTC 5024 followers, XXX engagements
"🦉 Lixisenatide reduced fusiform gyrus activation in obese diabetics (n=29). Lower caloric intake correlated with reduced brain response to food. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"
@AponiaAnalytics on X 2025-07-27 17:23:20 UTC 5024 followers, XXX engagements